Lethal factor unfolding is the most force-dependent step of anthrax toxin translocation.

Proceedings of the National Academy of Sciences of the United States of America
Katie L ThorenBryan A Krantz

Abstract

Cellular compartmentalization requires machinery capable of translocating polypeptides across membranes. In many cases, transported proteins must first be unfolded by means of the proton motive force and/or ATP hydrolysis. Anthrax toxin, which is composed of a channel-forming protein and two substrate proteins, is an attractive model system to study translocation-coupled unfolding, because the applied driving force can be externally controlled and translocation can be monitored directly by using electrophysiology. By controlling the driving force and introducing destabilizing point mutations in the substrate, we identified the barriers in the transport pathway, determined which barrier corresponds to protein unfolding, and mapped how the substrate protein unfolds during translocation. In contrast to previous studies, we find that the protein's structure next to the signal tag is not rate-limiting to unfolding. Instead, a more extensive part of the structure, the amino-terminal beta-sheet subdomain, must disassemble to cross the unfolding barrier. We also find that unfolding is catalyzed by the channel's phenylalanine-clamp active site. We propose a broad molecular mechanism for translocation-coupled unfolding, which is applicab...Continue Reading

References

Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R O BlausteinA Finkelstein
Jun 1, 1973·The Journal of General Physiology·A M Woodhull
Jul 14, 1995·Science·Y BaiS W Englander
Jan 10, 1998·The EMBO Journal·A MatouschekG Schatz
Dec 3, 1999·Nature Structural Biology·S HuangA Matouschek
Nov 21, 2001·The Journal of Biological Chemistry·D Borden LacyR John Collier
Mar 12, 2002·Nature Structural Biology·Shihai HuangAndreas Matouschek
Dec 19, 2002·Biophysical Chemistry·S Walter EnglanderJon N Rumbley
Feb 13, 2003·Current Opinion in Structural Biology·Andreas Matouschek
Aug 19, 2003·Nature Structural Biology·Mariano Carrion-VazquezJulio M Fernandez
Aug 19, 2003·Nature Structural Biology·David J BrockwellSheena E Radford
Jun 11, 2004·Biophysical Journal·Karim ShariffAndreas Matouschek
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Sep 21, 2004·Biophysical Journal·Sen ZhangAlan Finkelstein
Sep 30, 2004·Cell·Robert T SauerTania A Baker
Nov 10, 2004·Journal of Molecular Biology·Bryan A KrantzR John Collier
Nov 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sen ZhangR John Collier
Oct 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·D Borden LacyR John Collier
Dec 14, 2005·Journal of Molecular Biology·Bryan A KrantzR John Collier
Mar 6, 2007·Annual Review of Biochemistry·John A T Young, R John Collier
Jan 16, 2008·The Journal of Biological Chemistry·Andres F Oberhauser, Mariano Carrión-Vázquez

❮ Previous
Next ❯

Citations

Oct 13, 2012·Chemical Reviews·Ekaterina M Nestorovich, Sergey M Bezrukov
Aug 8, 2013·Journal of the American Chemical Society·Misha SoskineGiovanni Maglia
Mar 12, 2013·Nature Nanotechnology·David Rodriguez-Larrea, Hagan Bayley
Nov 3, 2010·Nature Structural & Molecular Biology·Geoffrey K FeldBryan A Krantz
Sep 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Audrey FischerR John Collier
Feb 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Phillip J ElmsSusan Marqusee
Oct 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Alexander F KintzerBryan A Krantz
Jan 12, 2010·The Journal of Biological Chemistry·Blythe E JanowiakR John Collier
Apr 22, 2011·The Journal of Biological Chemistry·Michael J BrownBryan A Krantz
Nov 2, 2012·The Journal of Biological Chemistry·Sarah L Wynia-SmithBryan A Krantz
Jun 1, 2011·The Journal of General Physiology·Daniel BasilioAlan Finkelstein
Jul 1, 2010·Toxins·Oludare OdumosuWilliam Langridge
Aug 26, 2014·Toxins·Philip A Gurnev, Ekaterina M Nestorovich
Jan 23, 2014·Expert Opinion on Drug Discovery·Ekaterina M Nestorovich, Sergey M Bezrukov
Sep 13, 2015·Journal of Molecular Biology·Jennifer M Colby, Bryan A Krantz
Dec 21, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wouter P R VerdurmenAndreas Plückthun
Oct 27, 2012·Archives of Biochemistry and Biophysics·Maksym Tsytlonok, Laura S Itzhaki
Jun 15, 2010·Current Opinion in Structural Biology·Neal Crampton, David J Brockwell
Jul 17, 2015·Scientific Reports·Amy E RabideauBradley L Pentelute
Mar 30, 2011·Molecular Microbiology·Katie L Thoren, Bryan A Krantz
Mar 1, 2012·Protein Science : a Publication of the Protein Society·Geoffrey K FeldBryan A Krantz
Aug 11, 2016·Proceedings of the National Academy of Sciences of the United States of America·Debasis Das, Bryan A Krantz
Sep 28, 2016·The Journal of General Physiology·Lucien FabreIsabelle Rouiller
Jan 25, 2017·Journal of Molecular Biology·Debasis Das, Bryan A Krantz
Dec 3, 2014·International Journal of Biological Macromolecules·Md Anzarul HaqueFaizan Ahmad
Sep 10, 2014·Nature Communications·David Rodriguez-Larrea, Hagan Bayley
Aug 22, 2013·The Journal of Biological Chemistry·David GigantiMarcelo E Guerin
Feb 24, 2016·Nanoscale·Zhonghe XuJingyuan Li
Jun 9, 2017·Biological Chemistry·Elena KudryashovaDmitri S Kudryashov
Aug 24, 2020·Archives of Biochemistry and Biophysics·Suet Y LoStefan Siemann
May 21, 2021·The Journal of Physical Chemistry. B·Goli YaminiEkaterina M Nestorovich
Aug 2, 2021·Biochimica Et Biophysica Acta. Biomembranes·Wenxing Liu, Ekaterina M Nestorovich
Mar 30, 2018·ACS Applied Materials & Interfaces·Christopher A BakerAnson V Hatch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.